Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Capodanno
Stephan Windecker

Showing results (541-550 of 2,161) with videos related to

Pageof 217
Sort By:
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 9, 2008
Early discharge in acute myocardial infarction after clinical and angiographic risk assessmentGiuseppina Branca, Davide Capodanno, Piera Capranzano, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|October 12, 2014
Risk prediction of contrast-induced nephropathy by ACEF score in patients undergoing coronary catheterizationDavide Capodanno, Margherita Ministeri, Fabio Dipasqua, et al.
Nephron Extra|April 4, 2012
Reference renal artery diameter is a stronger predictor of contrast-induced nephropathy than chronic kidney disease in patients with high cardiovascular riskLuca Zanoli, Stefania Rastelli, Carmelita Marcantoni, et al.
Heart (British Cardiac Society)|March 18, 2026
Post-acute coronary syndrome cardiovascular rehabilitation: insights into endpoints, biomarkers and clinical practiceLuigi Cutore, Denise Cristiana Faro, Carmelo Raffo, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 4, 2018
Will ORBITA change my practice? ORBITA trial: Objective Randomised Blinded Investigation with optimal medical Therapy of Angioplasty in stable anginaRobert Schueler, Rasha Al-Lamee, Felix Mahfoud, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 4, 2019
The EuroIntervention health check 2019Darren Mylotte, Robert A Byrne, Davide Capodanno, et al.
Circulation. Cardiovascular Interventions|December 25, 2009
Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery diseaseDavide Capodanno, Maria Elena Di Salvo, Glauco Cincotta, et al.
JACC. Cardiovascular Imaging|October 19, 2013
Are the culprit lesions severely stenotic?Giampaolo Niccoli, Giulio G Stefanini, Davide Capodanno, et al.
Journal of Cardiovascular Development and Disease|November 26, 2025
Diagnostic Predictive Scores of Amyloid Cardiomyopathy in Patients with Heart Failure with Preserved Ejection Fraction and Left Ventricular HypertrophyDenise Cristiana Faro, Fabrizia Romeo, Valentina Losi, et al.
Expert Review of Cardiovascular Therapy|August 11, 2020
Antithrombotic treatment in atrial fibrillation patients undergoing percutaneous coronary interventions: focus on stent thrombosisMarco Vitolo, Saad Javed, Davide Capodanno, et al.
Pageof 217

Showing results (541-550 of 2,161) with videos related to

Sort By:
Pageof 217
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 9, 2008
Early discharge in acute myocardial infarction after clinical and angiographic risk assessmentGiuseppina Branca, Davide Capodanno, Piera Capranzano, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|October 12, 2014
Risk prediction of contrast-induced nephropathy by ACEF score in patients undergoing coronary catheterizationDavide Capodanno, Margherita Ministeri, Fabio Dipasqua, et al.
Nephron Extra|April 4, 2012
Reference renal artery diameter is a stronger predictor of contrast-induced nephropathy than chronic kidney disease in patients with high cardiovascular riskLuca Zanoli, Stefania Rastelli, Carmelita Marcantoni, et al.
Heart (British Cardiac Society)|March 18, 2026
Post-acute coronary syndrome cardiovascular rehabilitation: insights into endpoints, biomarkers and clinical practiceLuigi Cutore, Denise Cristiana Faro, Carmelo Raffo, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 4, 2018
Will ORBITA change my practice? ORBITA trial: Objective Randomised Blinded Investigation with optimal medical Therapy of Angioplasty in stable anginaRobert Schueler, Rasha Al-Lamee, Felix Mahfoud, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 4, 2019
The EuroIntervention health check 2019Darren Mylotte, Robert A Byrne, Davide Capodanno, et al.
Circulation. Cardiovascular Interventions|December 25, 2009
Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery diseaseDavide Capodanno, Maria Elena Di Salvo, Glauco Cincotta, et al.
JACC. Cardiovascular Imaging|October 19, 2013
Are the culprit lesions severely stenotic?Giampaolo Niccoli, Giulio G Stefanini, Davide Capodanno, et al.
Journal of Cardiovascular Development and Disease|November 26, 2025
Diagnostic Predictive Scores of Amyloid Cardiomyopathy in Patients with Heart Failure with Preserved Ejection Fraction and Left Ventricular HypertrophyDenise Cristiana Faro, Fabrizia Romeo, Valentina Losi, et al.
Expert Review of Cardiovascular Therapy|August 11, 2020
Antithrombotic treatment in atrial fibrillation patients undergoing percutaneous coronary interventions: focus on stent thrombosisMarco Vitolo, Saad Javed, Davide Capodanno, et al.
Pageof 217